BLUEPRINT MEDICINES CORPORATION Research and Development Expense
BLUEPRINT MEDICINES CORPORATION reported Research and Development Expense of $91.89 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-01.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2025-05-01
- BLUEPRINT MEDICINES CORPORATION research and development expense for the quarter ending 2025-03-31 was $91.89M, a 4.19% increase year-over-year.
- BLUEPRINT MEDICINES CORPORATION research and development expense for the quarter ending 2024-12-31 was $83.67M, a 14.21% decline year-over-year.
- BLUEPRINT MEDICINES CORPORATION research and development expense for the quarter ending 2024-09-30 was $85.30M, a 22.63% decline year-over-year.
- BLUEPRINT MEDICINES CORPORATION research and development expense for the quarter ending 2024-06-30 was $84.27M, a 23.43% decline year-over-year.
- BLUEPRINT MEDICINES CORPORATION research and development expense for fiscal 2024 was $341.43M, a 20.17% decline from fiscal 2023.
- BLUEPRINT MEDICINES CORPORATION research and development expense for fiscal 2023 was $427.72M, a 10.41% decline from fiscal 2022.
- BLUEPRINT MEDICINES CORPORATION research and development expense for fiscal 2022 was $477.42M, a 20.57% decline from fiscal 2021.
- BLUEPRINT MEDICINES CORPORATION research and development expense for fiscal 2021 was $601.03M, a 83.88% increase from fiscal 2020.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2025-03-31 | $91.89M 10-Q · filed 2025-05-01 | $175.56M derived: sum of 2 quarters · filed 2025-05-01 | $260.86M derived: sum of 3 quarters · filed 2025-05-01 | $345.13M derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-12-31 | $83.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $168.97M derived: sum of 2 quarters · filed 2025-02-13 | $253.24M derived: sum of 3 quarters · filed 2025-02-13 | $341.43M 10-K · filed 2025-02-13 |
| 2024-09-30 | $85.30M 10-Q · filed 2024-10-30 | $169.57M derived: sum of 2 quarters · filed 2024-10-30 | $257.76M 10-Q · filed 2024-10-30 | $355.30M derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-06-30 | $84.27M 10-Q · filed 2024-08-01 | $172.46M 10-Q · filed 2024-08-01 | $270.00M derived: sum of 3 quarters · filed 2025-05-01 | $380.25M derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-03-31 | $88.19M 10-Q · filed 2025-05-01 | $185.73M derived: sum of 2 quarters · filed 2025-05-01 | $295.98M derived: sum of 3 quarters · filed 2025-05-01 | $406.04M derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $97.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $207.79M derived: sum of 2 quarters · filed 2025-02-13 | $317.85M derived: sum of 3 quarters · filed 2025-02-13 | $427.72M 10-K · filed 2025-02-13 |
| 2023-09-30 | $110.25M 10-Q · filed 2024-10-30 | $220.31M derived: sum of 2 quarters · filed 2024-10-30 | $330.18M 10-Q · filed 2024-10-30 | $450.23M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $110.06M 10-Q · filed 2024-08-01 | $222.13M 10-Q · filed 2024-08-01 | $339.98M derived: sum of 3 quarters · filed 2025-02-13 | $467.96M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $112.07M 10-Q · filed 2024-05-02 | $229.91M derived: sum of 2 quarters · filed 2025-02-13 | $357.89M derived: sum of 3 quarters · filed 2025-02-13 | $486.36M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $117.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $245.82M derived: sum of 2 quarters · filed 2025-02-13 | $374.29M derived: sum of 3 quarters · filed 2025-02-13 | $477.42M 10-K · filed 2025-02-13 |
| 2022-09-30 | $127.98M 10-Q · filed 2023-10-26 | $256.45M derived: sum of 2 quarters · filed 2023-10-26 | $359.58M 10-Q · filed 2023-10-26 | $716.46M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $128.47M 10-Q · filed 2023-08-02 | $231.60M 10-Q · filed 2023-08-02 | $588.48M derived: sum of 3 quarters · filed 2024-02-15 | $672.89M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $103.13M 10-Q · filed 2023-05-04 | $460.01M derived: sum of 2 quarters · filed 2024-02-15 | $544.43M derived: sum of 3 quarters · filed 2024-02-15 | $624.46M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $356.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $441.30M derived: sum of 2 quarters · filed 2024-02-15 | $521.32M derived: sum of 3 quarters · filed 2024-02-15 | $601.03M 10-K · filed 2024-02-15 |
| 2021-09-30 | $84.42M 10-Q · filed 2022-11-01 | $164.45M derived: sum of 2 quarters · filed 2022-11-01 | $244.16M 10-Q · filed 2022-11-01 | $321.56M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $80.03M 10-Q · filed 2022-08-02 | $159.74M 10-Q · filed 2022-08-02 | $237.14M derived: sum of 3 quarters · filed 2023-02-16 | $311.37M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $79.71M 10-Q · filed 2022-05-03 | $157.11M derived: sum of 2 quarters · filed 2023-02-16 | $231.34M derived: sum of 3 quarters · filed 2023-02-16 | $322.42M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $77.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $151.63M derived: sum of 2 quarters · filed 2023-02-16 | $242.71M derived: sum of 3 quarters · filed 2023-02-16 | $326.86M 10-K · filed 2023-02-16 |
| 2020-09-30 | $74.23M 10-Q · filed 2021-10-28 | $165.31M derived: sum of 2 quarters · filed 2021-10-28 | $249.46M 10-Q · filed 2021-10-28 | $338.10M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | $91.08M 10-Q · filed 2021-07-29 | $175.22M 10-Q · filed 2021-07-29 | $263.87M derived: sum of 3 quarters · filed 2022-02-17 | $345.32M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $84.15M 10-Q · filed 2021-04-29 | $172.79M derived: sum of 2 quarters · filed 2022-02-17 | $254.25M derived: sum of 3 quarters · filed 2022-02-17 | $341.35M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | $88.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $170.10M derived: sum of 2 quarters · filed 2022-02-17 | $257.20M derived: sum of 3 quarters · filed 2022-02-17 | $331.45M 10-K · filed 2022-02-17 |
| 2019-09-30 | $81.45M 10-Q · filed 2020-10-29 | $168.55M derived: sum of 2 quarters · filed 2020-10-29 | $242.80M 10-Q · filed 2020-10-29 | $313.34M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-30 | $87.10M 10-Q · filed 2020-07-30 | $161.35M 10-Q · filed 2020-07-30 | $231.88M derived: sum of 3 quarters · filed 2021-02-17 | $296.44M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-31 | $74.25M 10-Q · filed 2020-05-06 | $144.78M derived: sum of 2 quarters · filed 2021-02-17 | $209.34M derived: sum of 3 quarters · filed 2021-02-17 | $267.92M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-31 | $70.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $135.09M derived: sum of 2 quarters · filed 2021-02-17 | $193.67M derived: sum of 3 quarters · filed 2021-02-17 | $243.62M 10-K · filed 2021-02-17 |
| 2018-09-30 | $64.56M 10-Q · filed 2019-11-05 | $123.14M derived: sum of 2 quarters · filed 2019-11-05 | $173.09M 10-Q · filed 2019-11-05 | $216.72M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $58.57M 10-Q · filed 2019-08-01 | $108.53M 10-Q · filed 2019-08-01 | $152.16M derived: sum of 3 quarters · filed 2020-02-13 | $191.46M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $49.95M 10-Q · filed 2019-05-09 | $93.58M derived: sum of 2 quarters · filed 2020-02-13 | $132.88M derived: sum of 3 quarters · filed 2020-02-13 | $166.15M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $43.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $82.93M derived: sum of 2 quarters · filed 2020-02-13 | $116.20M derived: sum of 3 quarters · filed 2020-02-13 | $144.69M 10-K · filed 2020-02-13 |
| 2017-09-30 | $39.30M 10-Q · filed 2018-10-30 | $72.57M derived: sum of 2 quarters · filed 2018-10-30 | $101.06M 10-Q · filed 2018-10-30 | $125.13M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $33.27M 10-Q · filed 2018-08-01 | $61.76M 10-Q · filed 2018-08-01 | $85.83M derived: sum of 3 quarters · filed 2019-02-26 | $103.98M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $28.49M 10-Q · filed 2018-05-02 | $52.56M derived: sum of 2 quarters · filed 2019-02-26 | $70.71M derived: sum of 3 quarters · filed 2019-02-26 | $91.98M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $24.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $42.22M derived: sum of 2 quarters · filed 2019-02-26 | $63.50M derived: sum of 3 quarters · filed 2019-02-26 | $81.13M 10-K · filed 2019-02-26 |
| 2016-09-30 | $18.15M 10-Q · filed 2017-10-31 | $39.42M derived: sum of 2 quarters · filed 2017-10-31 | $57.06M 10-Q · filed 2017-10-31 | $73.49M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-06-30 | $21.27M 10-Q · filed 2017-08-02 | $38.91M 10-Q · filed 2017-08-02 | $55.34M derived: sum of 3 quarters · filed 2018-02-21 | $67.02M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-03-31 | $17.64M 10-Q · filed 2017-05-03 | $34.07M derived: sum of 2 quarters · filed 2018-02-21 | $45.75M derived: sum of 3 quarters · filed 2018-02-21 | $56.99M derived: sum of 4 quarters · filed 2018-02-21 |
| 2015-12-31 | $16.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $28.11M derived: sum of 2 quarters · filed 2018-02-21 | $39.35M derived: sum of 3 quarters · filed 2018-02-21 | $48.59M 10-K · filed 2018-02-21 |
| 2015-09-30 | $11.68M 10-Q · filed 2016-11-10 | $22.92M derived: sum of 2 quarters · filed 2016-11-10 | $32.16M 10-Q · filed 2016-11-10 | $43.49M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $11.24M 10-Q · filed 2016-08-09 | $20.48M 10-Q · filed 2016-08-09 | $31.81M derived: sum of 3 quarters · filed 2017-03-09 | $40.18M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | $9.23M 10-Q · filed 2016-05-10 | $20.57M derived: sum of 2 quarters · filed 2017-03-09 | $28.93M derived: sum of 3 quarters · filed 2017-03-09 | $35.70M derived: sum of 4 quarters · filed 2017-03-09 |
| 2014-12-31 | $11.33M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $19.70M derived: sum of 2 quarters · filed 2017-03-09 | $26.46M derived: sum of 3 quarters · filed 2017-03-09 | $31.84M 10-K · filed 2017-03-09 |
| 2014-09-30 | $8.37M 10-Q · filed 2015-11-09 | $15.13M derived: sum of 2 quarters · filed 2015-11-09 | $20.51M 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $6.76M 10-Q · filed 2015-08-10 | $12.14M 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | $5.38M 10-Q · filed 2015-06-11 | |||
| 2013-12-31 | $15.93M 10-K · filed 2016-03-11 |